Profiling Neutrophil Counts in Patients on Chemotherapy

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
NeoplasmsNeutropeniaFebrile Neutropenia
Interventions
DEVICE

Home finger-prick capillary blood count monitoring

A nurse will visit the participant's home according to the test schedule (up to a maximum frequency of 21 visits in a 21-day cycle) and perform the finger-prick capillary blood test and measure the neutrophil count using the Hemocue® WBC DIFF device.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Philips Healthcare

INDUSTRY

lead

University of Leeds

OTHER

NCT02806557 - Profiling Neutrophil Counts in Patients on Chemotherapy | Biotech Hunter | Biotech Hunter